Request Deal Involvement

Catalio Capital Management and ARCH Venture Partners led a $76m Series A round in Pheast Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

or

Principals

CATALIO CAPITAL MANAGEMENT

bidder

CATALIO CAPITAL MANAGEMENT

ARCH VENTURE PARTNERS

bidder

ARCH VENTURE PARTNERS

PHEAST

target

PHEAST

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Catalio Capital Management and ARCH Venture Partners led a $76m Series A round in Pheast Therapeutics.